NSI-189

$8.80 1000g

$9.90 10g

Min. Order10g
Purity99.99%HPLC.USP42——Powder、Oil、Pills、Capsules、Tablets，Customiz
Cas No1270138-40-3
Supply Ability1000kg/Month
Update time2022-02-23

Shanghai Biolang Biotechnology Co., Ltd.

4YR

China

Chemical Properties

Product Name	NSI-189
CAS No	1270138-40-3
EC-No
Min. Order	10g
Purity	99.99%HPLC.USP42——Powder、Oil、Pills、Capsules、Tablets，Customiz
Supply Ability	1000kg/Month
Release date	2022/02/23

NSI-189 structure	Common Name	NSI-189
CAS Number	1270138-40-3	Molecular Weight	366.500
Density	1.1±0.1 g/cm3	Boiling Point	534.7±50.0 °C at 760 mmHg
Molecular Formula	C22H30N4O	Melting Point	N/A
MSDS	N/A	Flash Point	277.2±30.1 °C

Company Profile Introduction

Shanghai Beilang was established in 2004. Its headquarter and foreign trade department are located in Shanghai, its R&D center is located in Optics Valley Bio-City, its logistics center is located in Wuhan Biomedical Park, and its production bases are located in Luotian, Tongshan, Dongying, Pingxiang and other places. Beilang Bio's business involves the research and development of innovative drugs, the screening of compound crystal forms, the custom synthesis of pharmaceutical intermediates and APIs, and the import and export business, as well as the outsourcing procurement and agent sales of pharmaceutical chemicals. In order to better serve customers, Beilang Bio has assembled a R&D team composed of 5 Ph.Ds, which can carry out process development and pilot scale-up production of multiple projects at the same time. At the same time, it has established more than 5,000 square meters of cGMP production. The base has passed the FDA's ready-made review, which can realize the g-kg-t rapid response of pharmaceutical intermediates. Not only that, it has also built a 1,000-square-meter logistics center in Wuhan, a thoroughfare of nine provinces, and has a spot reserve worth more than 10 million. , It can realize the quick response to 1w orders in a single day. Beilang Biology has cooperated with many well-known universities and scientific research institutions such as Wuhan University, Shanghai University, China Medical University, China Pharmaceutical University, Shenyang Pharmaceutical University, Shanghai Institutes of Biological Sciences, China Institute of Biotechnology in the development of new drugs. Cooperation. At the same time, it has extensively cooperated with major pharmaceutical companies such as CSPC, Huayao Group, and Langbo Pharmaceutical to jointly develop export business. For a long time, colleagues regard Biolang as a long-term and reliable partner. We also hope to carry out more cooperation with colleagues in the industry, and work towards a better tom